General MedicationsInjectionGeneric
NALBUPHINE
NALBUPHINE HYDROCHLORIDE
Standard Dose
20MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NALBUPHINE is listed in Drugs@FDA under application 070693 (ANDA).
Marketing status: Discontinued Active ingredient NALBUPHINE HYDROCHLORIDE Form and strength Injectable; Injection - 20MG/ML Sponsor QUAD PHARMS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview NALBUPHINE is listed in Drugs@FDA under application 070693 (ANDA). Marketing status: Discontinued Active ingredient NALBUPHINE HYDROCHLORIDE Form and strength Injectable; Injection - 20MG/ML Sponsor QUAD PHARMS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.